menu
    • menu

    Company profile for Osivax

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ​Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies based on its proprietary technology, oligoDOM®, which is designed to induce powerful CD8 T-cell responses. Osivax' mission is to revolutionize influenza prevention with a universal flu vaccine covering both current and future influenza infections by leveraging its unique oligoDOM® technology platform. Osivax was created ...
    ​Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies based on its proprietary technology, oligoDOM®, which is designed to induce powerful CD8 T-cell responses. Osivax' mission is to revolutionize influenza prevention with a universal flu vaccine covering both current and future influenza infections by leveraging its unique oligoDOM® technology platform. Osivax was created as a spin-off of Imaxio, a commercial-stage vaccine company, to accelerate the development of the oligoDOM® technology platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OsivaxFrance Flag
    Country
    Country
    France
    Address
    Address
    OSIVAX​​ ​99, rue de Gerland 69007 LYON
    Telephone
    Telephone
    +33 4 37 65 55 03
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://osivax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/osivax/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Osivax Starts Ph 2b Trial Of Broad-Spectrum Influenza A Vaccine
    Osivax Starts Ph 2b Trial Of Broad-Spectrum Influenza A Vaccine

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150564/0/en/Osivax-Announces-First-Participant-Vaccinated-in-Phase-2b-Trial-Evaluating-Broad-Spectrum-Influenza-A-Vaccine-Candidate-OVX836.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Osivax Secures $19.5M BARDA Award for Advanced Influenza Vaccine
    Osivax Secures $19.5M BARDA Award for Advanced Influenza Vaccine

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139049/0/en/Osivax-Receives-19-5M-BARDA-Award-to-Advance-Next-Generation-Influenza-Vaccine-for-Pandemic-and-Seasonal-Preparedness.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2a
    Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2a

    12 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/10/3113044/0/en/Osivax-Publishes-Phase-2a-Results-Supporting-Co-Administration-of-OVX836-with-Seasonal-Flu-Vaccine-in-Vaccines-Journal.html

    GLOBENEWSWIRE
    12 Jul 2025
    Share Share
    Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2A
    Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2A

    10 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/10/3113044/0/en/Osivax-Publishes-Phase-2a-Results-Supporting-Co-Administration-of-OVX836-with-Seasonal-Flu-Vaccine-in-Vaccines-Journal.html

    GLOBENEWSWIRE
    10 Jul 2025
    Share Share
    Osivax Announces Phase 2a Trial Completion for Influenza Vaccine
    Osivax Announces Phase 2a Trial Completion for Influenza Vaccine

    05 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/05/3094167/0/en/Osivax-Announces-Last-Patient-Last-Visit-in-Phase-2a-Trial-Evaluating-a-Booster-Dose-of-Broad-Spectrum-Influenza-Vaccine-OVX836-s-release.html

    GLOBENEWSWIRE
    05 Jun 2025
    Share Share
    Osivax Secures Funding To Advance Influenza Vaccine Development
    Osivax Secures Funding To Advance Influenza Vaccine Development

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250303843963/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search